TABLE 1.
HSV prevalence in cutaneous specimens by patient age
Age (yr) |
illumigene HSV 1 |
illumigene HSV 2 |
||||
---|---|---|---|---|---|---|
Total no. | Total no. positivea | Prevalence (%)b | Total no. | Total no. positivea | Prevalence (%)b | |
≤5 | 38 | 12 | 31.6 | 38 | 1 | 2.6 |
6–18 | 42 | 18 | 42.9 | 42 | 4 | 9.5 |
19–55 | 177 | 20 | 11.3 | 177 | 37 | 20.9 |
>55 | 49 | 4 | 8.2 | 49 | 13 | 26.5 |
Not provided | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
Positivity was calculated based on the illumigene results.
Specimens resulting in invalid results were removed for prevalence analysis (no.).